A stable and strong anti-interference ability serum phospholipid detection reagent and detection method
A technology for detecting reagents and serum phospholipids, applied in biochemical equipment and methods, microbial determination/inspection, etc., can solve the problems of reagents causing great harm to operators, difficult to realize automatic operation, poor reagent stability, etc., and achieve enhanced anti-interference. ability, meeting clinical needs, and improving the effect of stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Serum phospholipid detection reagents, including reagent R1 and reagent R2:
[0036] 1) The composition of its R1 is:
[0037]
[0038] 2) The components of reagent R2 are:
[0039]
[0040] 3) The usage method of the reagent of this embodiment:
[0041] The serum phospholipid detection reagent described in this example is used in an automatic biochemical analyzer with dual reagent functions, such as Hitachi 7180 automatic analyzer, etc., and is determined by the endpoint method. Place R1 and R2 on the corresponding reagent positions according to the ratio of 4:1, and place distilled water, standards and samples on the corresponding positions of the sample tray. The operation is shown in Table 1:
[0042] Table 1 Example 1 reagent detection method
[0043]
[0044] Calculation: Serum phospholipid content (mg / dL) = (ΔA determination ÷ ΔA standard) × C standard.
Embodiment 2
[0046] Interference test: take fresh mixed serum, divide it into 2 equal parts, then divide each equal part into 5 equal parts, add different interfering substances, so that the concentration in the serum reaches the requirements in Table 2. Then respectively use the reagent obtained in Example 1, and compare the content of PLIP in the blood serum with the serum phospholipid (PLIP) reagent that is common and recognized in the market. The measured results of the control group and the measured results of each group after adding different interference substances are shown in Table 2. Relative deviation (%) = (measuring mean value of interference samples - measuring mean value of control samples) / measuring mean value of control samples × 100%.
[0047] It can be seen from Table 2 that the reagent of Example 1 has no obvious interference on the test results when ascorbic acid≤50mg / dL, bilirubin≤40mg / dL, triglyceride≤1250mg / dL, and hemoglobin≤400mg / dL. However, the reagents of the...
Embodiment 3
[0052] Correlation experiment: using the formula in Example 1 to prepare reagents, and conducting a control test with a phospholipid kit from a company approved by the State Food and Drug Administration, which is common in the market, and testing 20 clinical serum samples at the same time, the test results are shown in Table 3 . And obtained the correlation curve of the two reagents (such as figure 1 As shown), the test results show that the correlation coefficient of the two kits is 0.9997, which shows that the two have a great correlation.
[0053] Table 3 Example 1 reagents and market common and recognized serum phospholipid assay kit comparative detection results
[0054]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com